Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Single agent, canfosfamide (C, TLK286) vs pegylated liposomal doxorubicin (D) or topotecan (T) in 3rd-line treatment of platinum (P) refractory or resistant ovarian cancer (OC): phase 3 study results [Abstract]
This apparent loss of reactive species production ex vivo is further supported by our observation that the antioxidant BHA, used as a positive control, did not enhance antibiotic killing in these conditions (Extended Data Fig
If you don't, use the time to identify a supervised setting that matches your safety needs and your professional obligations
That familiar morning stiffness turned into persistent tenderness that forced me to cut training volume by half
US$ 23.12
US$ 26.23
US$ 25.00
US$ 20.71
US$ 25.84
US$ 24.82
